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to assess barriers and motivators to adherence in research
settings, and may be predictive of adherence.
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EDMONTON QUALITY ASSESSMENT TOOL FOR 
DRUG UTILIZATION REVIEWS (EQATDUR):
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METHODOLOGIC RIGOR OF DRUG 
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Spooner CH, Pickard AS, Menon D, Assiff L
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OBJECTIVE: The purpose of this project was: 1) to de-
velop an instrument that would provide a systematic ap-
proach to evaluating the methodological rigor of published
drug utilization reviews (DURs) and DUR programs; and
2) to determine the inter-rater reliability of the instrument’s
adequacy to discriminate between high and low quality
studies. 
METHODS: Based upon guidelines that have been ac-
cepted for appraising controlled clinical trials and before
and after studies, a multidisciplinary panel identified ar-
eas where bias could be introduced in the design and con-
duct of DURs. These areas included selection bias in the
sample selection; detection bias in the data collection; se-
lection, detection and exclusion bias if an intervention
occurred; and observer bias in the data analysis. Items
constituting the criteria to be met were generated for
each section. The item content, instructions and scoring
system of the EQATDUR were reviewed and revised by
clinical and methodological experts. The instrument was
piloted and re-tested for inter-rater reliability among rat-
ers from four relevant backgrounds using twenty pub-
lished community and hospital based DUR studies evalu-
ating antibiotic use. 
RESULTS: The present version of the EQATDUR in-
cludes five sections, each containing two to four criteria
to detect the presence of relevant systematic bias. The in-
strument produced strong inter-rater agreement as repre-
sented by an intra class correlation coefficient of 0.76
calculated from the aggregate score for each article. 
CONCLUSION: The EQATDUR has the potential to be
a useful tool that can assist researchers to determine the
strength of the methodological quality of DUR studies.
POR4
LINGUISTIC VALIDATION OF THE SLICE/LIFE 
QUESTIONNAIRE
Conway K1, Pouget C1, Keller MB2, Walker C2, Leventhal N2, 
Revicki D3, Namjoshi M4, Tohen M4,5
1Mapi Research Institute, Lyon, France; 2Brown University, 
Providence, RI, USA; 3Medtap International, Bethesda, MD, 
USA; 4Eli Lilly and Company, Indianapolis, IN, USA; 5Harvard 
Medical School, Boston, MA, USA
Quality of life (QoL) assessment has become a vital part
of international clinical trials. This has made it necessary
to produce cross-culturally valid instruments to make
comparisons of health status outcomes and pool data
across countries. The SLICE/LIFE questionnaire is a 11-
item instrument developed in US English to measure the
impact of psychological disorders on patients’ lives. Prior
to use in an international trial including patients with bi-
polar disorders, the original questionnaire underwent lin-
guistic validation in 16 languages. 
METHODS: This process involved the recruitment of a
QoL specialist in each country. Two forward translations
were produced by two native target language speakers,
fluent in English. These were reconciled and back-trans-
lated into English. The clarity and appropriateness of the
wording were tested in a sample target population, com-
pared and internationally harmonized. The developers
clarified concepts underlying problematic items. 
RESULTS: This process gave rise to linguistic and cul-
tural issues. These included finding a suitable equivalent
for the notion of “impairment” for which different syn-
tactic structures were adopted in most translations. Fur-
thermore, it was impossible to maintain a literal transla-
tion of the term “partner” in conjunction with “someone
you live with” as the interpretation of the two concepts
differed across countries. Finally, as in most cultures it
would have sounded insulting to employ a literal transla-
tion of “mental illness” in the context of a questionnaire,
more adapted expressions needed to be found. 
CONCLUSION: A rigorous methodology ensured con-
ceptual equivalence and acceptability of the translations.
Psychometric testing will be conducted to ensure reliability
and validity of each translation, appropriateness of the
questionnaire in each country, and comparability of data
across countries.
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OBJECTIVE: The purpose of this study was to determine
the applicability of a multiple criteria decision technique to
the evaluation of new drug agents for formulary placement
in managed care settings. The Analytic Hierarchy Process
(AHP), developed by Dr. Thomas Saaty in 1977, which
utilizes pair-wise comparisons among all feasible alterna-
tive agents within a hierarchical breakdown of the organi-
zation’s decision-making preference structure, was utilized
to determine the best choice for formulary inclusion. 
METHODS: The analytical hierarchy process was used
to screen three drug agents used in the treatment of rheu-
matoid arthritis. This methodology employs a stepwise
procedure: 1) Identify alternative drug agents being con-
sidered for formulary inclusion; 2) Define organizational
preference structure (decision criteria); 3) Quantify the
preference of each agent relative to every other agent be-
